Pfizer, whose shares have lost almost a quarter of their value in the past three years, said it plans to be the first company to meet regularly with shareholders to discuss executive pay and management practices.
The first meeting will be in the third quarter with about 30 investors who together hold 35 percent of the New York-based company's shares, Pfizer spokesman Andy McCormick said in a telephone interview today.
The first meeting will be in the third quarter with about 30 investors who together hold 35 percent of the New York-based company's shares, Pfizer spokesman Andy McCormick said in a telephone interview today.
Pfizer's top shareholders include Barclays Global Investors Ltd., State Street Corp. and Vanguard Group Inc., according to data compiled by Bloomberg.
1 comment:
Meeting only for surveillance purposes, don't be fooled!
Post a Comment